IP Library Granted Patent US 9,938,544
Granted Patent B2
US 9,938,544 · App. 15/644,239 · Granted Apr 10, 2018

Biological methods for preparing a fatty dicarboxylic acid

Inventors: Tom Beardslee (Carlsbad, CA); Stephen Picataggio (Carlsbad, CA); L. Dudley Eirich (Carlsbad, CA); Jose Miguel Laplaza (Carlsbad, CA)
Assignee: Verdezyne, Inc.
C12P7/6409C12N1/16C12N1/28C12N9/0042C12N9/0071C12N15/815C12P7/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,544
App. No.
15/644,239
Granted
Apr 10, 2018
Kind
B2
Abstract

The technology relates in part to biological methods for producing a fatty dicarboxylic acid and engineered microorganisms capable of such production.

Claims (20)

1. A method for producing a diacid, comprising:

contacting a genetically modified yeast with a feedstock capable of being converted by the yeast to a diacid; and

culturing the yeast under conditions in which the diacid is produced from the feedstock,

wherein the genetically modified yeast comprises: one or more genetic modifications that substantially block beta oxidation activity; and one or more genetic modifications that increase ADH2a alcohol dehydrogenase activity, wherein ADH2a alcohol dehydrogenase comprises the amino acid sequence of SEQ ID NO: 115.

2. The method of claim 1 , wherein the genetically modified yeast comprises one or more genetic modifications that increase a monooxygenase activity.

3. The method of claim 2 , wherein the monooxygenase comprises CYP52A12, CYP52A13, CYP52A14, CYP52A15, CYP52A16, CYP52A17, CYP52A18, CYP52A19 or CYP52A20.

4. The method of claim 1 , wherein the genetically modified yeast comprises one or more genetic modifications that increase a monooxygenase reductase activity.

5. The method of claim 4 , wherein the monooxygenase reductase is cytochrome p450 reductase B (CPRB).

6. The method of claim 1 , wherein the genetically modified yeast comprises one or more genetic modifications that disrupt activity of a POX4 polypeptide or a POX5 polypeptide.

7. The method of claim 1 , wherein the genetically modified yeast is a Candida spp. yeast.

8. The method of claim 7 , wherein the Candida spp. yeast is chosen from C. tropicalis and C. viswanathii.

9. The method of claim 7 , wherein the Candida spp. yeast is a genetically modified ATCC20336 yeast.

10. The method of claim 1 , wherein the feedstock comprises a substantially pure oil.

11. The method of claim 1 , wherein the feedstock comprises a plurality of fatty acids.

12. The method of claim 1 , wherein the feedstock comprises one or more components from a vegetable oil.

13. The method of claim 12 , wherein the vegetable oil is from a plant chosen from palm, palm kernel, coconut, soy, safflower, canola or combination thereof.

14. The method of claim 1 , wherein the diacid contains one or more unsaturations.

15. The method of claim 1 , wherein the diacid is a C8, C10, C12, C14, C16, C18 or C20 diacid.

16. The method of claim 15 , wherein the diacid is a C12 diacid.

17. The method of claim 1 , wherein the diacid is dodecanedioic acid or 12-hydroxydodecanoic acid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2020
From: VERDEZYNE, INC.
To: VERDEZYNE (ABC) LLC
Reel/Frame 051706/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2020
From: VERDEZYNE (ABC) LLC
To: RADICI CHIMICA S.P.A.
Reel/Frame 051791/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2017
From: BEARDSLEE, TOM; PICATAGGIO, STEPHEN; EIRICH, L. DUDLEY; LAPLAZA, JOSE MIGUEL
To: VERDEZYNE, INC.
Reel/Frame 043092/0345 →
Continuity (4)
Division 14131170
Provisional Application 61505092 · Jul 6, 2011
Provisional Application 61523216 · Aug 12, 2011
Related Publication 20180030486A1 · Feb 1, 2018